疫苗

China hands record fine to manufacturer of faulty vaccines

Chinese vaccine maker Changsheng Biotech has been hit with penalties totalling more than Rmb9.1bn ($1.3bn) after the company falsified data in the production of rabies vaccines, causing national outrage.

Police detained Changsheng chairwoman Gao Junfang in July after regulators said the company had distributed hundreds of thousands of “substandard” rabies and diphtheria, tetanus and pertussis vaccines to medical centres. 

Regulators in the province of Jilin, where the company is based, this week seized income of Rmb1.89bn from the sale of the defective vaccines and fined Changsheng Rmb7.21bn — three times the value of those sales. 

您已閱讀29%(637字),剩餘71%(1524字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×